Helicobacter pylori prevalence and clinical significance in patients with quiescent Crohn's disease.

Background: Helicobacter pylori (HP) infection is present in about 50% of the global population, and is associated with chronic gastritis, peptic disease and gastric malignancies. HP prevalence in Crohn's disease (CD) patients was shown to be low compared to the general population, and its influence...

Descripción completa

Detalles Bibliográficos
Publicado en:BMC Gastroenterology Vol. 17; pp. 1 - 7
Autores principales: Lahat, Adi, Kopylov, Uri, Neuman, Sandra, Levhar, Nina, Yablecovitch, Doron, Avidan, Benjamin, Weiss, Batia, Ben-Horin, Shomron, Eliakim, Rami
Formato: Journal Article
Publicado: BioMed Central 2/13/2017
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=121260584&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 121260584
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        1471230X
        1CHO
      jtl: BMC Gastroenterology
      issn: 1471230X
      maglogo: N
    pubinfo:
      dt: 2/13/2017
      vid: 17
      pid: 24147
      pub: BioMed Central
    artinfo:
      ui:
        121260584
        121260584
        NLM28193167
        10.1186/s12876-017-0588-7
        NLM28193167
        121260584
      ppf: 1
      ppct: 6
      formats:
      tig:
        atl: Helicobacter pylori prevalence and clinical significance in patients with quiescent Crohn's disease.
      aug:
        au:
          Lahat, Adi
          Kopylov, Uri
          Neuman, Sandra
          Levhar, Nina
          Yablecovitch, Doron
          Avidan, Benjamin
          Weiss, Batia
          Ben-Horin, Shomron
          Eliakim, Rami
        affil: Department of Gastroenterology, Sheba Medical Center, Tel Hashomer, Tel Hashomer, Israel
      sug:
        subj:
          Helicobacter Infections Epidemiology
          Crohn Disease Microbiology
          Helicobacter Pylori
          Capsule Endoscopy
          Helicobacter Infections Complications
          Magnetic Resonance Imaging Methods
          Middle Age
          Crohn Disease Pathology
          Antibiotics Therapeutic Use
          Prevalence
          Female
          Feces Microbiology
          Male
          Feces
          Helicobacter Infections Drug Therapy
          C-Reactive Protein Analysis
          Crohn Disease
          Adult
          Disease Eradication
          Severity of Illness Indices
          Arthritis Impact Measurement Scales
          Questionnaires
          Scales
          Middle Aged: 45-64 years
          Adult: 19-44 years
          Female
          Male
      ab: Background: Helicobacter pylori (HP) infection is present in about 50% of the global population, and is associated with chronic gastritis, peptic disease and gastric malignancies. HP prevalence in Crohn's disease (CD) patients was shown to be low compared to the general population, and its influence on disease activity is yet to be determined. Our aims were to determine the prevalence of HP in a selected group of CD patients with quiescent disease, and to assess the influence of its eradication on disease activity and endoscopic and laboratory activity measures.Methods: Consecutive CD patients with quiescent disease underwent meticulous disease evaluation with MR enterography (MRE), video capsule endoscopy (VCE), CRP, fecal calprotectin and CDAI. All patients were tested for the presence of HP using stool antigen detection kit. Patients infected with HP were offered eradication treatment with sequential therapy. HP eradication was confirmed using urease breath test and stool antigen test. The influence of HP eradication on disease activity was assessed.Results: Out of 56 patients enrolled, six patients (10.7%) had HP infection. Of them, five patients had gastro- duodenitis per VCE. All HP positive patients were offered eradication treatment and underwent successful eradication. Notably, 23 (50%) of patients had proximal disease per VCE, most of them (78%) were HP negative. CDAI, CRP, fecal calprotectin and VCE Lewis inflammatory score did not change significantly following HP eradication, Gastric findings on VCE were not impacted by HP eradication.Conclusions: The prevalence of HP infection in patients with quiescent CD is relatively low. Eradication of the bacteria did not significantly change neither disease activity measures nor the presence of gastro- duodenitis per VCE, suggesting it might be part of proximal CD. The influence of HP on CD activity merits further investigation.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N